FDA inspection
Shandong Xinhua Pharmaceutical Co., Ltd. First Plant: FDA inspection ending Sep 15, 2023
FDA inspection 1220079 · No Action Indicated (NAI) · Zibo
Key facts
| Inspection ID | 1220079 |
|---|---|
| Firm | Shandong Xinhua Pharmaceutical Co., Ltd. First Plant |
| FEI number | 3002808153 |
| Address | Zibo High & New Technology, East Chemical Zone Dev. Zone |
| City | Zibo |
| Country | China |
| Fiscal year | 2023 |
| Inspection end date | Sep 15, 2023 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data